您使用提示模式 关闭

1621 - Nomura Next Funds Topix-17 Pharmaceutical ETF (JPY) (JP3046600007)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

全选 清除所有
 
(%)
JP3046600007
1621 ISIN
交易所交易基金 (ETF)
基金类型
Nomura Asset Management
提供商
-
每股资产净值
2008-03-21
成立日期
2 每年的次数
股息的支付
CECIES
CFI
1621
代码
Formed
Status
Equity
投资项目
Healthcare
部门
Japan
地区分布
TOPIX-17 Pharmaceutical Index
基准
0.32 %
总成本比率
Physical
复制方法
否
UCITS
Passive (Index)
Management Style

最新数据在
添加比较项目
从
至
ADD-IN
Cbonds 加载项 API
债券数据 API

报价 (1621)

探索最全面的数据库

1 000 000

债券

80 234

股票

167 970

ETF & Funds

8万

指数

以最有效的方式跟踪您的投资组合

  • 债券筛选器
  • 观察列表
  • Excel 附加组件
请求访问

价格动态的变化

Fund profile

The Nomura Next Funds Topix-17 Pharmaceutical ETF seeks to replicate as closely as possible the price and yield performance of the Topix-17 Pharmaceutical Index by investing in a portfolio comprised primarily of Japanese pharmaceutical companies

1621 profile

The Nomura Next Funds Topix-17 Pharmaceutical ETF (JPY) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Healthcare sector located in Japan. The Nomura Asset Management fund’s base currency is JPY and the share class was registered 21.03.2008 with unique ISIN - JP3046600007. Main exchange is Tokyo S.E. and ticker symbol is 1621. The total expense ratio is 0.32%. The Nomura Next Funds Topix-17 Pharmaceutical ETF (JPY) pays dividends 2 time(s) per year.

其他 ETF 和基金提供商

你必须 注册 才能获得访问权